Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1250-1255
Published online before print April 14, 2005, doi: 10.1161/01.ATV.0000166518.96137.38
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/6/1250    most recent
01.ATV.0000166518.96137.38v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonçalves, I.
Right arrow Articles by Nilsson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonçalves, I.
Right arrow Articles by Nilsson, J.
Related Collections
Right arrow Pathophysiology
Right arrow Carotid Stenosis
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1250.)
© 2005 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Humoral Immune Response Against Defined Oxidized Low-Density Lipoprotein Antigens Reflects Structure and Disease Activity of Carotid Plaques

Isabel Gonçalves; Marie-Louise M. Gronholdt; Ingrid Söderberg; Mikko P.S. Ares; Borge G. Nordestgaard; Jacob F. Bentzon; Gunilla Nordin Fredrikson; Jan Nilsson

From the Departments of Medicine (I.G., I. S., M.P.S.A., G.N.F., J.N.) and Cardiology (I.G.), Lund University, Wallenberg Laboratory, University Hospital MAS, Malmö, Sweden; the Department of Vascular Surgery (M.L.G.), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; the Department of Clinical Biochemistry (B.N.), Herlev University Hospital, University of Copenhagen, Copenhagen, Denmark; and the Department of Coronary Pathology Research (J.F.B.), Skejby University Hospital, Århus, Denmark.

Correspondence to Isabel Gonçalves, University of Lund, Wallenberg Laboratory, University Hospital MAS, SE-20502 Malmö, Sweden. E-mail isabel.goncalves{at}medforsk.mas.lu.se

Background— Immune responses against oxidized low-density lipoprotein (LDL) play an important role in atherosclerosis. The aim of this study was to investigate if humoral immune response against specific oxidized LDL antigens, such as aldehyde-modified peptide sequences of apolipoprotein B-100, reflects disease activity and structure of atherosclerotic plaques.

Methods and Results— Plaques were obtained from 114 symptomatic subjects referred to carotid endarterectomy and characterized immunohistochemically and histologically. Plasma levels of IgG and IgM against aldehyde-modified apolipoprotein B-100 amino acid sequences 661 to 680, 3136 to 3155 (peptide 210), and 3661 to 3680 (peptide 240) were determined by enzyme-linked immunosorbent assay. High levels of IgG against peptide 210 were associated with increased plaque content of lipids (r=0.24, P<0.05) and hemorrhage (r=0.27, P=0.005), with decreased content of fibrous tissue (r=–0.25, P=0.01), but also with lower total plaque volume (r=–0.21, P<0.05). In contrast, high levels of IgM against peptide 240 were associated with plaques with more fibrous tissue (r=0.35, P<0.001), less lipids (r=–0.34, P<0.001), and less macrophages (r=–0.24, P<0.05). IgM against peptide 210 were found to be associated with plaque fibrous tissue (r=0.20, P<0.05), less lipids (r=–0.21, P<0.05), and less macrophages (r=–0.27, P=0.01).

Conclusion— These findings support the notion that immune responses against oxidized LDL epitopes are involved in atherosclerosis and that the level of circulating antibodies against these structures may reflect disease activity in the arterial wall.

Immune responses against oxidized low-density lipoprotein (LDL) are important in atherosclerosis. This study demonstrates that IgG and IgM against defined epitopes in oxidized LDL reflects the structure and disease activity of atherosclerotic plaques.


Key Words: antibodies • atherosclerosis • carotid plaque • carotid stenosis • modified low-density lipoprotein




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
M. E. Hettema, H. Bootsma, and C. G. M. Kallenberg
Macrovascular disease and atherosclerosis in SSc
Rheumatology, May 1, 2008; 47(5): 578 - 583.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Stoll and M. Bendszus
Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization
Stroke, July 1, 2006; 37(7): 1923 - 1932.
[Abstract] [Full Text] [PDF]